Skip to search formSkip to main contentSkip to account menu

Oncogene, RET

Known as: MEN2B, RET, ret oncogene 
Human Oncogene RET is a mutated variant of RET Gene, which encodes Tyrosine-Protein Kinase Receptor RET, a type I membrane protein receptor for Glial… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Multiple endocrine neoplastic type 2 (MEN2) is an endocrine carcinoma syndrome which is caused by a germline… 
2016
2016
  • Hugh Thomas
  • 2016
  • Corpus ID: 21883356
In response to environmental cues, intestinal glial cells secrete factors that alter the function of group 3 innate lymphoid… 
2015
2015
Introduction: Recent studies have shown that the receptor tyrosine kinase RET is involved in the biology of ER positive breast… 
2014
2014
Thyroid cancer is a malignant neoplasm that originates from follicular or parafollicular thyroid cells and is categorized as… 
2009
2009
RET (reliability enhancement testing) is the most advanced technology from western countries. RET's concept, process and stress… 
1999
1999
Activating mutations of the RET proto-oncogene cause hereditary medullary thyroid carcinoma. To examine whether selective… 
1989
1989
Several possible mechanisms for the initiation and progression of tumors in multiple endocrine neoplasia type 2 (MEN 2) merit… 
Review
1989
Review
1989
The mapping of the locus for multiple endocrine neoplasia type 2A (MEN 2A) to chromosome 10 using linkage is briefly reviewed…